Dopamine d2 Receptor Antikörper (AA 1-110)
(1 reference)-
- Target Alle Dopamine d2 Receptor (DRD2) Antikörper anzeigen
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
-
Bindungsspezifität
- AA 1-110
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Dopamine d2 Receptor Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant DRD2.
- Sequenz
- MDPLNLSWYD DDLERQNWSR PFNGSDGKAD RPHYNYYATL LTLLIAVIVF GNVLVCMAVS REKALQTTTN YLIVSLAVAD LLVATLVMPW VVYLEVVGEW KFSRIHCDIF
- Kreuzreaktivität
- Human
- Immunogen
- DRD2 (AAH21195, 1 a.a. ~ 110 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 1B11
- Isotyp
- IgG2a kappa
- Top Product
- Discover our top product DRD2 Primärantikörper
-
anti-Dopamine Receptor D2 (DRD2) (AA 194-421) antibody
DRD2 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 201-300) antibodyDRD2 Reaktivität: Human, Ratte, Maus WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (Cytoplasmic Domain) antibodyDRD2 Reaktivität: Human, Hund, Fledermaus, Rind (Kuh), Pferd, Kaninchen IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 307-336), (C-Term) antibodyDRD2 Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) antibodyDRD2 Reaktivität: Hund WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 301-400) antibodyDRD2 Reaktivität: Human, Ratte, Maus WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 201-300) antibody (AbBy Fluor® 488)DRD2 Reaktivität: Human, Ratte, Maus WB, IF (cc), IF (p) Wirt: Kaninchen Polyclonal AbBy Fluor® 488
anti-Dopamine Receptor D2 (DRD2) (AA 214-373) antibodyDRD2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 11-26), (Extracellular), (N-Term) antibodyDRD2 Reaktivität: Human, Ratte, Maus WB Wirt: Kaninchen Polyclonal unconjugated
anti-Dopamine Receptor D2 (DRD2) (AA 11-26), (Extracellular), (N-Term) antibody (FITC)DRD2 Reaktivität: Human, Ratte, Maus FACS Wirt: Kaninchen Polyclonal FITC
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Kommentare
-
Product Quality tested by: Antibody Reactive Against Recombinant Protein.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In ascites fluid
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
: "SCH23390, a dopamine D1 receptor antagonist, suppressed scratching behavior induced by compound 48/80 in mice." in: European journal of pharmacology, Vol. 670, Issue 1, pp. 162-7, (2011) (PubMed).
-
: "SCH23390, a dopamine D1 receptor antagonist, suppressed scratching behavior induced by compound 48/80 in mice." in: European journal of pharmacology, Vol. 670, Issue 1, pp. 162-7, (2011) (PubMed).
-
- Target
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
- Andere Bezeichnung
- DRD2 (DRD2 Produkte)
- Hintergrund
-
Full Gene Name: dopamine receptor D2
Synonyms: D2DR,D2R - Gen-ID
- 1813
- Pathways
- Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
-
